ZTS - Zoetis Inc.

NYSE - NYSE Delayed Price. Currency in USD

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
http://www.zoetis.com

SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees10,600

Key executives

NameTitlePayExercisedYear born
Ms. Kristin C. PeckCEO & Director1.54M2.28M1971
Mr. Glenn C. DavidExec. VP & CFO1.44M1M1972
Mr. Juan Ramón AlaixAdvisor & Director3.57M19.21M1951
Dr. Catherine A. KnuppExec. VP and Pres of R&D1.42M5.21M1961
Ms. Roxanne LaganoExec. VP and Chief HR Officer & Global OperationsN/AN/A1965
Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides, which prevent or eliminate external and internal parasites comprising fleas, ticks, and worms. It also provides other pharmaceutical products comprising pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, such as nutritionals and agribusiness, as well as products and services in the areas of biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Corporate governance

Zoetis Inc.’s ISS governance QualityScore as of 4 December 2019 is 5. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 9; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.